Key Segmentation:
By Technology
-
Serological Test
-
Lymphocytic Transformation Test
-
Urine Antigen Testing
-
Immunofluorescent Staining
-
Nucleic Acid Test
By Sample Type
-
Blood
-
Urine
-
CSF
-
Other Blood Samples
By Patient Type
-
Adult
-
Pediatric
By End Use
-
Hospitals
-
Diagnostic Laboratories
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
The Lyme Disease Testing Market is expected to grow at a CAGR of 8.56% from 2026 to 2035.
The Lyme Disease Testing Market was valued at USD 12.15 Billion in 2025.
Rising Lyme disease incidence from climate change-driven tick habitat expansion into previously non-endemic regions creating new testing volume streams, and technological advancement in next-generation serological and molecular diagnostic platforms improving accuracy and expanding addressable market value per diagnostic episode.
Serological Test dominated the Lyme Disease Testing Market with approximately 38.45% share in 2025, while Nucleic Acid Test is the fastest growing segment.
North America dominated the Lyme Disease Testing Market in 2025, reflecting the extraordinary U.S. disease burden of approximately 476,000 annual diagnoses that creates the world's largest single-country Lyme disease diagnostic testing market.